Clinical Trials

Showing trials with last updates posted in 2026.

NCT06900595 | RECRUITING | PHASE2
48 participants

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2026-02-22
Completion:
2029-06-02
Conditions
  • Locally Advanced Adrenal Cortical Carcinoma
  • Metastatic Adrenal Cortical Carcinoma
  • Recurrent Adrenal Cortical Carcinoma
  • Stage III Adrenal Cortical Carcinoma AJCC v8
  • Stage IV Adrenal Cortical Carcinoma AJCC v8
  • Unresectable Adrenal Cortical Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06884176 | WITHDRAWN | NA
0 participants

CVCs Versus Midline Catheters

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2026-06-30
Completion:
2027-06-30
Conditions
  • Central Venous Catheter
  • Midline Catheter
  • Complication of Catheter
Interventions
  • DEVICE
No Results Yet
NCT06827236 | RECRUITING | PHASE1/PHASE2
380 participants

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2025-04-23
Completion:
2029-08-31
Conditions
  • Locally Advanced Breast Cancer
  • Unresectable Breast Carcinoma
  • Metastatic Breast Cancer
Interventions
  • DRUG
No Results Yet
NCT06814795 | ACTIVE_NOT_RECRUITING | NA
32 participants

Medically Tailored Meals for Kids

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-27
Start Date:
2025-11-25
Completion:
2026-10-21
Conditions
  • Pediatric Cancer
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page